An Introduction to Risk Management
March 30, 2017 Azita Alavi Regional Manager Harvard Risk Management Corporation While it may be impossible to eliminate all risk, Harvard Risk Management consultants work with companies to help reduc [...]
Biotech Investing with Versant Ventures
March 28, 2017Graham G. WalmsleyVersant VenturesGraham Walmsley is an Associate at Versant Ventures focused on biotechnology and healthcare investments. Graham joined Versant after completing his trai [...]
CIRM 2.0: Funding Translation of Stem Cell Based Treatments in California
March 24, 2017 Shyam Patel, Senior Science Officer, California Institute for Regenerative Medicine The California Institute for Regenerative Medicine (CIRM) is California’s stem cell agency. Some the [...]
Fraud Prevention Seminar
March 23, 2017 Eddie Contreras, Senior Director, Fraud Prevention Debi Kutaka, Senior Fraud Risk Manager Silicon Valley Bank While early-stage entrepreneurs take big risks, they often ignore the subs [...]
Safety Assessment for the Investigational New Drug (IND) Application
March 21, 2017 Sue McPherson, Executive Director of Toxicology WuXi AppTec The success of an Investigational New Drug (IND) applications is one of the key milestones of the drug development process. [...]
Amgen Seminar and Office Hours
March 17, 2017 12:30 PM Networking and Lunch 1:00 PM "From bench to bedside - and you thought molecule identification was difficult!" Sean Lybrand, Director of Value, Access and Policy, Amgen Austral [...]
Planning for Business Income Taxes and Best Practices
March 3, 2017 Bong Hillberg Lewis Fischesser LLP Many pitfalls await the entrepreneur filing taxes for his or her startup. Mixing personal and business taxes, failing to account for expenses properly [...]
Making the Most of the Online Fundraising Platforms
February 24, 2017 Office Hours: Greg Naeve Head, Strategic Research Partnerships, San Francisco at Pfizer Pfizer Come meet Pfizer's head of research partnerships in the Bay Area, Greg Naeve. To apply [...]
Amgen Innovator Series Enable Awesome: Bootstrapping a Diagnostic from Idea to Industry
February 22, 2017 David Seftel, CSO and Peter Robinson, CEO Enable Biosciences Enable Biosciences is a recent addition to the QB3@953 family - a spinout from the PhD work of a pair of Berkeley / Stan [...]